Literature DB >> 15616906

[Economic aspects of intensive care medicine--cost and reimbursement according to diagnosis related grouping].

A Billing1, M Thalhammer, H-J Eissner, K-W Jauch, D Inthorn.   

Abstract

We analyse relevant modifications of the new German diagnosis related reimbursement system for 2004. It is difficult to judge the consequences of financing intensive care systems by such flat rates. In our surgical ICU total treatment costs were 1 050.-euro /day and 11 530.-euro /patient. Comparison of our total costs and German federal calculation 2003 for long-term ventilation revealed that our costs resulting from a tertiary unit topped the average by 36-60 %. Already the present reimbursement was not cost rewarding. Evaluation according to the 2003 criteria resulted in profound further deterioration to a cost covering of only 49 %. The 2004 system, however, allows for better differentiation of patients and should result in improved reimbursement of long-term ventilation. Further professional analysis of the DRG system is essential for its "learning" development.

Entities:  

Mesh:

Year:  2004        PMID: 15616906     DOI: 10.1055/s-2004-832392

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  5 in total

1.  [Intensive care capacities in Germany: provision and usage between 1991 and 2009].

Authors:  R Thattil; D Klepzig; M Schuster
Journal:  Anaesthesist       Date:  2012-01       Impact factor: 1.041

2.  [Cases and duration of mechanical ventilation in German hospitals : An analysis of DRG incentives and developments in respiratory medicine].

Authors:  A Biermann; A Geissler
Journal:  Anaesthesist       Date:  2016-08-05       Impact factor: 1.041

Review 3.  [Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view].

Authors:  R Riedel; A Schmieder; A Koster; S Kim; G Baumgarten; J C Schewe
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-12-22       Impact factor: 0.840

4.  [Cost of intensive care in a German hospital: cost-unit accounting based on the InEK matrix].

Authors:  J Martin; C Neurohr; M Bauer; M Weiss; A Schleppers
Journal:  Anaesthesist       Date:  2008-05       Impact factor: 1.041

5.  Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital setting.

Authors:  Peter Kaskel; Silja Tuschy; Alexander Wagner; Christian Bannert; Oliver A Cornely; Axel Glasmacher; Hans-Peter Lipp; Andrew J Ullmann
Journal:  Ann Hematol       Date:  2007-10-11       Impact factor: 3.673

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.